126 related articles for article (PubMed ID: 18353870)
1. Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model.
Nishimura H; Ito Y; Mizuno M; Tanaka A; Morita Y; Maruyama S; Yuzawa Y; Matsuo S
Am J Physiol Renal Physiol; 2008 May; 294(5):F1084-93. PubMed ID: 18353870
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide ameliorates peritoneal fibrosis in rat peritonitis model.
Kato H; Mizuno T; Mizuno M; Sawai A; Suzuki Y; Kinashi H; Nagura F; Maruyama S; Noda Y; Yamada K; Matsuo S; Ito Y
Nephrol Dial Transplant; 2012 Feb; 27(2):526-36. PubMed ID: 21669883
[TBL] [Abstract][Full Text] [Related]
3. The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis.
Zhang L; Hao JB; Ren LS; Ding JL; Hao LR
Lab Invest; 2014 Aug; 94(8):839-50. PubMed ID: 24862968
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity.
Pérez-Rojas J; Blanco JA; Cruz C; Trujillo J; Vaidya VS; Uribe N; Bonventre JV; Gamba G; Bobadilla NA
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F131-9. PubMed ID: 16835406
[TBL] [Abstract][Full Text] [Related]
5. Direct aldosterone action as a profibrotic factor via ROS-mediated SGK1 in peritoneal fibroblasts.
Yamahara H; Kishimoto N; Nakata M; Okazaki A; Kimura T; Sonomura K; Matsuoka E; Shiotsu Y; Adachi T; Matsubara H; Iwasaka T; Mori Y
Kidney Blood Press Res; 2009; 32(3):185-93. PubMed ID: 19521108
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal mesothelial cells as a target of local aldosterone action: upregulation of connective tissue growth factor expression via serum- and glucocorticoid-inducible protein kinase 1.
Okazaki A; Mori Y; Nakata M; Kimura T; Sonomura K; Sakoda C; Matsuoka E; Ishida M; Yamahara H; Kishimoto N; Nakagawa H; Matsubara H
Kidney Blood Press Res; 2009; 32(3):151-60. PubMed ID: 19468237
[TBL] [Abstract][Full Text] [Related]
7. Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.
Toyonaga J; Tsuruya K; Ikeda H; Noguchi H; Yotsueda H; Fujisaki K; Hirakawa M; Taniguchi M; Masutani K; Iida M
Nephrol Dial Transplant; 2011 Aug; 26(8):2475-84. PubMed ID: 21220752
[TBL] [Abstract][Full Text] [Related]
8. Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum- and glucocorticoid-regulated kinase type 1.
Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Valero-Muñoz M; Vassallo D; Davel AP; Rossoni LV; Cachofeiro V; Lahera V
Exp Physiol; 2012 Jun; 97(6):710-8. PubMed ID: 22327331
[TBL] [Abstract][Full Text] [Related]
9. Effects of glucose and plasminogen activator inhibitor-1 on collagen metabolism in the peritoneum.
Higuchi C; Tanihata Y; Nishimura H; Naito T; Sanaka T
Ther Apher Dial; 2005 Apr; 9(2):173-81. PubMed ID: 15828931
[TBL] [Abstract][Full Text] [Related]
10. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
11. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
13. Role of rosiglitazone in lipopolysaccharide-induced peritonitis: a rat peritoneal dialysis model.
Song SH; Kwak IS; Yang BY; Lee DW; Lee SB; Lee MY
Nephrology (Carlton); 2009 Apr; 14(2):155-63. PubMed ID: 19207869
[TBL] [Abstract][Full Text] [Related]
14. Long-term mineralocorticoid receptor blockade ameliorates progression of experimental diabetic renal disease.
Lian M; Hewitson TD; Wigg B; Samuel CS; Chow F; Becker GJ
Nephrol Dial Transplant; 2012 Mar; 27(3):906-12. PubMed ID: 21908416
[TBL] [Abstract][Full Text] [Related]
15. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Subeq YM; Ke CY; Lin NT; Lee CJ; Chiu YH; Hsu BG
Cytokine; 2011 Feb; 53(2):223-30. PubMed ID: 21129996
[TBL] [Abstract][Full Text] [Related]
16. Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone.
Mejía-Vilet JM; Ramírez V; Cruz C; Uribe N; Gamba G; Bobadilla NA
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F78-86. PubMed ID: 17376767
[TBL] [Abstract][Full Text] [Related]
17. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum.
Margetts PJ; Bonniaud P; Liu L; Hoff CM; Holmes CJ; West-Mays JA; Kelly MM
J Am Soc Nephrol; 2005 Feb; 16(2):425-36. PubMed ID: 15590759
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen Sulfide Alleviates Peritoneal Fibrosis via Attenuating Inflammation and TGF-β1 Synthesis.
Lu Y; Gao L; Li L; Zhu Y; Wang Z; Shen H; Song K
Nephron; 2015; 131(3):210-9. PubMed ID: 26529331
[TBL] [Abstract][Full Text] [Related]
20. Mineralocorticoid receptor antagonist spironolactone prevents pig serum-induced hepatic fibrosis in rats.
Fujisawa G; Muto S; Okada K; Kusano E; Ishibashi S
Transl Res; 2006 Sep; 148(3):149-56. PubMed ID: 16938653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
